Bacille Calmette-Guérin Site Reactivation of Kawasaki Disease in Infants under 3 Months of Age: Relation with Diagnosis and Prognosis

Roh, Daeun; Kwon, Jae Wan; Kim, Yeo Hyang

doi:10.3390/children9060857

Cited by 3 publications

(2 citation statements)

References 22 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Importantly, post-COVID KD was characterized by a higher incidence of cervical lymphadenopathy and a lower incidence of BCG site changes than KD. The significantly higher incidence of cervical lymphadenopathy and lower frequency of BCGitis in group 1 may be associated with the older median age of group 1 ( 40 – 44 ).…”

Section: Discussionmentioning

confidence: 97%

Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications

et al. 2022

Self Cite

View full text Add to dashboard Cite

BackgroundHerein we investigate the difference between Kawasaki disease (KD) with and without a recent history of SARS-CoV-2 infection.MethodsWe compared the clinical characteristics of patients with KD during the SARS-CoV-2 pandemic in a single children's hospital in Korea. Fifty-two patients were enrolled and divided into group 1 (with a history of COVID-19, n = 26) and group 2 (without a history of COVID-19, n = 26) according to whether or not they contracted COVID-19 within the 8 weeks before hospitalization. Data, including clinical features and laboratory results, were analyzed and compared between groups.ResultsThe median age of patients was significantly higher in group 1 than in group 2 (53 months [IQR, 24–81] vs. 15 months [IQR, 6–33], p = 0.001). The incidence of cervical lymphadenopathy was significantly higher (p = 0.017), while that of BCGitis was significantly lower in group 1 (p = 0.023), and patients had a significantly longer hospital stay (5 days [IQR, 3–8] vs. 3 days [IQR, 3–4], p = 0.008). In group 1, platelet count was significantly lower (p = 0.006), and hemoglobin and ferritin levels were significantly higher (p = 0.013 and p = 0.001, respectively) on the first admission day. Following treatment with intravenous immunoglobulin (IVIG), the platelet count was significantly lower (p = 0.015), and the percentage of neutrophils and neutrophil-to-lymphocyte ratio were significantly higher in group 1 (p = 0.037 and p = 0.012). Although there was no statistical difference, patients requiring infliximab treatment due to prolonged fever was only in group 1. The incidence of cardiovascular complications did not differ between the groups.ConclusionsPost-COVID KD showed a stronger inflammatory response than KD-alone, with no differences in cardiac complications.

show abstract

Section: Discussionmentioning

confidence: 97%

Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…In this Special Issue, dedicated to "Cardiovascular Disease in Children", we are covering some of these aspects. From middle-term outcomes after anatomical surgery [7]; through application of percutaneous interventional techniques in rare paediatric syndromes [8]; vasovagal syncope [9]; the role of neonatal therapeutic hypothermia on QTc interval prolongation [10]; to echocardiography applications and perspectives [11,12]; inflammatory conditions such as Kawasaki disease in young infants and children [13] and multisystem inflammatory syndrome [12,14]; prevalence variations in arterial hypertension around the COVID-19 pandemic [15]; up to the exciting field of vascular health and cardiovascular biomarkers [16,17], we are inviting you on an inspiring journey.…”

mentioning

confidence: 99%